Centessa Pharmaceuticals plc CNTA
CNTA
Centessa Pharmaceuticals plc GLUE
Monte Rosa Therapeutics, Inc. NAMS
NewAmsterdam Pharma Company N.V. IVA
Inventiva S.A. CGEM
Cullinan Therapeutics, Inc. CMPX
Compass Therapeutics, Inc. IPSC
Century Therapeutics, Inc. EWTX
Edgewise Therapeutics, Inc. DAWN
Day One Biopharmaceuticals, Inc. DSGN
Design Therapeutics, Inc.
Centessa Pharmaceuticals plc GLUE
Monte Rosa Therapeutics, Inc. NAMS
NewAmsterdam Pharma Company N.V. IVA
Inventiva S.A. CGEM
Cullinan Therapeutics, Inc. CMPX
Compass Therapeutics, Inc. IPSC
Century Therapeutics, Inc. EWTX
Edgewise Therapeutics, Inc. DAWN
Day One Biopharmaceuticals, Inc. DSGN
Design Therapeutics, Inc.
Performance
| Periode | CNTA | GLUE | NAMS | IVA | CGEM | CMPX | IPSC | EWTX | DAWN | DSGN |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 95.07 % | 134.36 % | 156.12 % | 33.78 % | -2.47 % | 141.47 % | 16.25 % | 31.13 % | 1.19 % | 125.61 % |
| YTD | 28.97 % | 39.10 % | 49.17 % | 110.05 % | -39.31 % | 193.21 % | -46.35 % | -44.60 % | -43.31 % | 5.67 % |
| 1Y | 35.47 % | 101.02 % | 102.11 % | 68.35 % | -53.67 % | 108.38 % | -62.30 % | -52.94 % | -49.62 % | 26.60 % |
| 3Y | 438.66 % | 25.83 % | 287.64 % | -15.19 % | -41.62 % | 35.03 % | -94.52 % | 40.08 % | -64.94 % | -59.55 % |
| 5Y | 3.77 % | -53.31 % | 264.92 % | -67.38 % | -74.86 % | -51.71 % | -97.56 % | -50.08 % | -69.34 % | -84.29 % |
| 10Y | 3.77 % | -53.31 % | 264.92 % | -66.51 % | -74.86 % | -51.71 % | -97.56 % | -50.08 % | -69.34 % | -84.29 % |
| From the beginning | 3.77 % | -53.31 % | 264.92 % | -66.51 % | -74.86 % | -51.71 % | -97.56 % | -50.08 % | -69.34 % | -84.29 % |